FK506 bypasses the effect of erythroferrone in cancer cachexia skeletal muscle atrophy
- DOI
- 10.1016/j.xcrm.2023.101306
- Published
- 2023-12
- Container
- Cell Reports Medicine
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.xcrm.2023.101306,
title = {FK506 bypasses the effect of erythroferrone in cancer cachexia skeletal muscle atrophy},
author = {Erica Mina and Elisabeth Wyart and Roberta Sartori and Elia Angelino and Ivan Zaggia and Valentina Rausch and Mara Maldotti and Alessia Pagani and Myriam Y. Hsu and Alberto Friziero and Cosimo Sperti and Alessio Menga and Andrea Graziani and Emilio Hirsch and Salvatore Oliviero and Marco Sandri and Laura Conti and Léon Kautz and Laura Silvestri and Paolo E. Porporato},
year = {2023},
journal = {Cell Reports Medicine},
doi = {10.1016/j.xcrm.2023.101306},
url = {https://doi.org/10.1016/j.xcrm.2023.101306}
}RIS
TY - JOUR TI - FK506 bypasses the effect of erythroferrone in cancer cachexia skeletal muscle atrophy AU - Erica Mina AU - Elisabeth Wyart AU - Roberta Sartori AU - Elia Angelino AU - Ivan Zaggia AU - Valentina Rausch AU - Mara Maldotti AU - Alessia Pagani AU - Myriam Y. Hsu AU - Alberto Friziero AU - Cosimo Sperti AU - Alessio Menga AU - Andrea Graziani AU - Emilio Hirsch AU - Salvatore Oliviero AU - Marco Sandri AU - Laura Conti AU - Léon Kautz AU - Laura Silvestri AU - Paolo E. Porporato PY - 2023 JO - Cell Reports Medicine DO - 10.1016/j.xcrm.2023.101306 UR - https://doi.org/10.1016/j.xcrm.2023.101306 ER -
APA
Mina, E., Wyart, E., Sartori, R., Angelino, E., Zaggia, I., Rausch, V., Maldotti, M., Pagani, A., Hsu, M. Y., Friziero, A., Sperti, C., Menga, A., Graziani, A., Hirsch, E., Oliviero, S., Sandri, M., Conti, L., Kautz, L., Silvestri, L., & Porporato, P. E. (2023). FK506 bypasses the effect of erythroferrone in cancer cachexia skeletal muscle atrophy. Cell Reports Medicine. https://doi.org/10.1016/j.xcrm.2023.101306
Source records
- crossref · retrieved 2026-09-26T21:49:59.863Z